secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akebia Therapeutics, Inc. (AKBA)
CIK:        0001517022
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001193125-23-137688
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Akebia shareholders reject 1-for-5 to 1-for-20 reverse stock split at special meeting
--------------------------------------------------------------------------------

- Reverse stock split (Proposal 1a) not approved: 77,934,578 for, 57,085,942 against, 563,365 abstain.
- Proportional authorized share reduction (Proposal 1b) also not approved: 78,473,738 for, 54,949,341 against.
- Adjournment proposal approved: 77,956,153 for, 56,291,429 against, 0 broker non-votes.
- Proposal 2 (authorized shares adjustment) withdrawn after Proposal 1b failed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517022/000119312523137688/0001193125-23-137688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517022/000119312523137688/d417546d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-137688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer